TICKERNERD
Menu
THCTHCHealthcare · Medical Care Facilities

THC Stock Forecast: Tenet Healthcare Corp. Price Predictions for 2026-2027

Last close, 24 Aug 2026
$279
−0.78% on the day

The 22 Wall Street analysts covering Tenet Healthcare Corp. hold a median 12-month price target of $283 — +1.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 97 of 100 as at 22 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$22.6B
Ticker Nerd rank
97 / 100
Median analyst target
$283
Analysts covering
22
Total return, dividends reinvested
1W
+5.3%
1M
+19.5%
YTD
+40.2%
1Y
+55.2%
From 52W high
−0.8%
From 52W low
+72.6%
$161
$281
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

THC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Tenet Healthcare Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
97 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
94
Revisions
92
Momentum
86
Quality
85
Growth
83
Issuance
82
Accruals
56
Volatility
45
Size
10

Value (94): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Volatility (45): The share price moves around a lot.

Size (10): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

THC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on THC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$150$200$250$300Oct 25Jan 26Apr 26Jul 26THCHigh $309Median $283Low $260

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says22 analysts
19 Buy3 Hold0 Sell
Low $260Median $283High $309

The green dot is the last close — the median target sits +1.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 11 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
3 Aug 2026Wells FargoMaintainsOverweight$231 → $281
28 July 2026BairdMaintainsNeutral$210 → $280
28 July 2026GuggenheimMaintainsBuy$242 → $283
28 July 2026Truist SecuritiesMaintainsBuy$270 → $290
27 July 2026Morgan StanleyMaintainsOverweight$254 → $274
27 July 2026RBC CapitalMaintainsOutperform$236 → $283
27 July 2026TD CowenMaintainsBuy$233 → $263
27 July 2026UBSMaintainsBuy$288 → $308
24 July 2026BarclaysMaintainsOverweight$240 → $271
24 July 2026BarclaysMaintainsOverweight—
20 July 2026GuggenheimMaintainsBuy—
20 July 2026GuggenheimMaintainsBuy$252 → $242
13 July 2026Wells FargoMaintainsOverweight—
13 July 2026Wells FargoMaintainsOverweight$213 → $231
9 July 2026BarclaysMaintainsOverweight$238 → $240
9 July 2026BarclaysMaintainsOverweight—
22 June 2026TD CowenMaintainsBuy—
5 May 2026BairdMaintainsNeutral—
5 May 2026BarclaysMaintainsOverweight—
4 May 2026Stephens & Co.MaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. THC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

THC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+19.2%
Analysts raising
18
Analysts cutting
0
Fundamentals

Tenet Healthcare Corp. (THC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
10.7×

Cheaper than 58% of US stocks

Price / sales
1.0×

Cheaper than 70% of US stocks

Price / book
4.8×

Cheaper than 23% of US stocks

EV / EBITDA
7.7×

Cheaper than 47% of US stocks

Growth & margins
Revenue growth (YoY)
6.8%

Higher than 43% of US stocks

Earnings growth (YoY)
186.8%

Higher than 89% of US stocks

Gross margin
83.7%

Higher than 93% of US stocks

Operating margin
18.2%

Higher than 77% of US stocks

Net margin
10.3%

Higher than 70% of US stocks

Returns & dividend
Return on equity
37.3%

Higher than 90% of US stocks

Return on assets
8.3%

Higher than 89% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

THC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
THCTenet Healthcare Corp.$22.6B
97
EHCEncompass Health Corp.$11.9B
81
DVADaVita, Inc.$11.6B
90
UHSUniversal Health Services, Inc.$10.4B
66
ENSGThe Ensign Group, Inc.$10.4B
67
CHEChemed Corp.$7.3B
89
PACSPACS Group, Inc.$6.9B
93

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Tenet Healthcare Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest THC news & analysis

Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why

Zacks Investment Research · 24 Aug 2026positive

Zacks Investment Research published a piece titled "Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why," stating that Tenet is well positioned to outperform the market as it exhibits above-average growth in its financials.

Why it matters — A Tenet watcher would care because the report highlights THC as a growth stock with above-average financial growth that is positioned to outperform the broader market.

Tenet (THC) Is Considered a Good Investment by Brokers: Is That True?

Zacks Investment Research · 20 Aug 2026neutral

Zacks examines whether Tenet Healthcare (THC) is considered a good investment by brokers, noting that Wall Street analyst recommendations are widely relied on by investors for buy, sell, or hold decisions. The piece observes that media reports about brokerage analysts changing their ratings often affect a stock's price.

Why it matters — A THC watcher would care because shifts in broker ratings and analyst sentiment can influence the stock's price and investor decisions.

Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?

Zacks Investment Research · 17 Aug 2026positive

Tenet Healthcare's hospital growth is driving earnings momentum, with stronger volumes, revenues, and margins helping to offset weakness in its exchange business, according to Zacks Investment Research.

Why it matters — THC watchers would care because hospital segment strength is offsetting exchange weakness and underpinning the company's ongoing earnings momentum.

Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks

Zacks Investment Research · 17 Aug 2026positive

Zacks Investment Research highlighted Tenet Healthcare Corp. (THC) among five top-ranked stocks, including CNC, FTNT, U, and GS, that are expected to beat earnings estimates in their upcoming releases.

Why it matters — The article suggests that THC is viewed favourably by analysts ahead of its earnings report, indicating potential strength in its upcoming financial results.

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

Zacks Investment Research · 14 Aug 2026neutral

Zacks Investment Research published a piece questioning whether investors are currently undervaluing Tenet Healthcare (THC), while emphasizing its Zacks Rank system that focuses on earnings estimates and estimate revisions, alongside value, growth, and momentum trends.

Why it matters — A THC watcher would care because the article highlights valuation and earnings-estimate trends that Zacks uses to screen stocks, which may inform how the market is pricing the company.

FAQ

Frequently asked questions about THC stock

What is the THC stock price forecast for 2026-2027?

The 22 Wall Street analysts covering Tenet Healthcare Corp. have a median 12-month price target of $283, with estimates ranging from $260 to $309. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is THC stock a buy right now?

Of the 22 analysts covering Tenet Healthcare Corp., 19 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Tenet Healthcare Corp. 97 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank THC?

As at 22 Aug 2026, Tenet Healthcare Corp. ranks 97 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (94 of 100).

Will THC stock go up?

No one can know that. What the data says: the median 12-month target from 22 analysts implies +1.6% from the last close, and Ticker Nerd's factor model ranks Tenet Healthcare Corp. 97 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the THC stock forecast for 2030?

No analyst covering Tenet Healthcare Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for THC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $260 to $309 over the next 12 months.

How has THC stock performed over the past year?

Tenet Healthcare Corp. returned +55.2% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Tenet Healthcare Corp. do?

Tenet Healthcare Corporation is a diversified healthcare services company based in Dallas, Texas. It operates a broad network of acute care and specialty hospitals, ambulatory surgery centers, and other outpatient facilities across the United States, often under the United Surgical Partners International brand and other partnerships.

What is the latest news on THC?

The most recent item we track (Zacks Investment Research, 24 Aug 2026): "Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why". Zacks Investment Research published a piece titled "Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why," stating that Tenet is well positioned to outperform the market as it exhibits above-average growth in its financials.

Company

About Tenet Healthcare Corp.

Tenet Healthcare Corporation is a diversified healthcare services company based in Dallas, Texas. It operates a broad network of acute care and specialty hospitals, ambulatory surgery centers, and other outpatient facilities across the United States, often under the United Surgical Partners International brand and other partnerships. The company’s hospital operations provide general and specialized inpatient care, including surgical services, emergency care, intensive and critical care, diagnostic imaging, and ancillary outpatient services. Its ambulatory care business focuses on same-day surgical procedures and outpatient treatment, serving patients seeking efficient, lower-intensity care settings. Tenet Healthcare Corporation also delivers revenue cycle management and related administrative solutions through Conifer Health Solutions, supporting hospitals, health systems, and physician groups with billing, collections, and clinical revenue integrity services. Founded in 1967 and headquartered in Dallas, Tenet Healthcare Corporation plays a significant role in the U.S. healthcare market as a large, for-profit provider spanning inpatient, outpatient, and administrative services.

CEO Dr. Saumya Sutaria M.D. · 77,000 employees · United States · https://www.tenethealth.com